SCHEMBL12360

SCHEMBL12360

CC1CC(C)N(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12104096 1.00 — —
SCHEMBL3430471 1.00 — —
SCHEMBL12104106 1.00 — —
SCHEMBL8748332 1.00 — —
SCHEMBL2609215 1.00 — —
SCHEMBL18573365 1.00 — —
SCHEMBL12570742 1.00 — —
SCHEMBL24743621 0.80 EPHX2 (0.48) —
SCHEMBL22363782 0.78 MAPT (0.31) —
SCHEMBL10416262 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253537-A1 HYDROGENATION PROCESS JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2021-08-19 — — US claimed
CN-112424168-A Hydrogenation process 庄信万丰股份有限公司 2021-02-26 — — CN claimed
WO-2024044334-A2 METHODS AND COMPOSITIONS FOR MODULATING KRAS(G12D) RANOK THERAPEUTICS (HANGZHOU) CO. LTD. (CN) 2024-02-29 — — WO disclosed
US-20230348459-A1 PYRROLIDINE COMPOUND AND USE THEREOF SIMCERE PHARMACEUTICAL CO., LTD. (CN) 2023-11-02 — — US disclosed
CN-107848967-B Cyclic quaternary ammonium salts as fuel or lubricant additives 因诺斯佩克有限公司 2022-05-27 — — CN disclosed
WO-2021228210-A1 PYRROLIDINE COMPOUND AND USE THEREOF 江苏先声药业有限公司 2021-11-18 — — WO disclosed
US-20210253537-A1 HYDROGENATION PROCESS JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2021-08-19 — — US disclosed
CN-112424168-A Hydrogenation process 庄信万丰股份有限公司 2021-02-26 — — CN disclosed
US-10689589-B2 Cyclic quaternary ammonium salts as fuel or lubricant additives INNOSPEC LIMITED (GB) 2020-06-23 — — US disclosed
US-20180223203-A1 CYCLIC QUATERNARY AMMONIUM SALTS AS FUEL OR LUBRICANT ADDITIVES INNOSPEC LIMITED (GB) 2018-08-09 — — US disclosed
CN-107848967-A As fuel or the cyclic quaternary ammonium salts of lubricant additive 因诺斯佩克有限公司 2018-03-27 — — CN disclosed
US-20100226882-A1 LINKED DIIMIDAZOLE ANTIVIRALS ENANTA PHARMACEUTICALS, INC. 2010-09-09 — — US disclosed
US-20100221215-A1 LINKED DIBENZIMIDAZOLE DERIVATIVES ENANTA PHARMACEUTICALS, INC. 2010-09-02 — — US disclosed
US-20090163492-A1 Substituted Oxindole Derivatives, Drugs Containing Said Derivatives and the Use Thereof ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2009-06-25 — — US disclosed
US-20090131444-A1 Aminopiperidine Quinolines and Their Azaisosteric Analogues with Antibacterial Activity ASTRAZENECA AB (SE) 2009-05-21 — — US disclosed
US-20080312270-A1 COMPOUNDS AND METHODS USEFUL FOR TREATING ASTHMA AND ALLERGIC INFLAMMATION AMGEN INC. 2008-12-18 — — US disclosed
US-7157487-B2 Vla-4 inhibitors DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-01-02 — — US disclosed
US-4599343-A Perfluoroindolizines and emulsions thereof useful as blood substitutes THE GREEN CROSS CORPORATION (JP) 1986-07-08 — — US disclosed
US-4596810-A Synthetic blood THE GREEN CROSS CORPORATION (JP) 1986-06-24 — — US disclosed
US-4591599-A Perfluoropyrrolizines and emulsions thereof useful as blood substitutes THE GREEN CROSS CORPORATION (JP) 1986-05-27 — — US disclosed
Send feedback